CDK6 and melanoma: Likewise, 5-aminolevulinic acid-mediated sonodynamic therapy (ALA-SDT) treated melanoma cells showed increased intracellular ROS levels and miR-34a expression, which acted synergistically to inhibit the expression of pro-proliferative factors Cyclin D1 and CDK6 to suppress cell cycle progression [41].